are bpc-157 and tb-500 fda approved vs TB-500: Research Compared fda approval status bpc-157 tb-500

BPC-157 has been proposed as a potential treatment of physiologically based illnesses that disproportionately affect certain patient populations, such as the COVID-19 illness, as it improves vascular integrity and immune response, reduces the pro-inflammatory profile, has an anti-inflammatory effect, and reduces the lethality of critical COVID-19 illnesses [3]

Sikiric, P., Kokot, A., Kralj, T., Zlatar, M., Masnec, S., Lazi, R., Lonari, K., Oroz, K., Sabli, M., Boljesic, M., Antunovi, M., Sikiri, S., trbe, S., Stambolija, V., Orekovi, B., Kavelj, I., Novosel, L., Zubcic, S., Krezic, I., krti, A., Jurjevi, I., Blagai, B., Seiwerth, S., & Stareini, M

Responsible planning and patience are the only real solutions

About 80-90% of an intramuscular dose up to 50 mcg is retained in the body